Science

Andelyn Biosciences, a CDMO, partnered with Odylia Therapeutics to manufacture a novel gene therapy (OT-004) to treat vision loss caused by mutations in the RPGRIP1 gene, which leads to rapid decline in function of the photoreceptor cells of the retina, resulting in a rare type of vision loss that c...

Feb. 1 marked the kickoff of the Life Sciences Communication Department’s 2023 science communication colloquium series. Professor and Taylor-Bascom Chair Dietram Scheufele was the first to present for the weekly series, speaking on “The pitfalls of not being scientific about science communicatio...